News Lilly offers AI discovery models to biotech partners Eli Lilly is offering AI-powered drug discovery models developed at a cost of around $1 billion to biotech companies for free.
News Survey reveals 'trust gap' in the value of AI to cardiology It seems cardiologists are more optimistic than patients about the potential of AI in helping cardiac teams improve care and save lives.
News Novartis taps Atropos AI for earlier PNH diagnoses Novartis teams up with real-world evidence specialist Atropos Health, hoping to speed up the diagnosis and treatment of rare disease PNH.
News EMA seeks input on virtual alternative to animal test EMA delivers a milestone in the replacement of animals in drug testing with the qualification of a virtual model for repeat-dose toxicity studies.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
